Tioga TMVR System
Severe Mitral Regurgitation (MR)
Pre-clinical/InvestigationalActive
Key Facts
Indication
Severe Mitral Regurgitation (MR)
Phase
Pre-clinical/Investigational
Status
Active
Company
About Tioga Cardiovascular
Tioga Cardiovascular is an early-stage, pre-revenue medical device innovator targeting the large and underserved market for transcatheter mitral valve replacement (TMVR). Its core technology is the Tioga TMVR System, which features a unique two-component design—a valve with a large atrial brim and a separate anchor that captures the native chordae—aimed at reducing paravalvular leak and left ventricular outflow tract obstruction risks. As a portfolio company of Shifamed, Tioga leverages experienced leadership from the medtech industry but faces significant clinical, regulatory, and competitive hurdles common to novel cardiovascular device development.
View full company profile